Mannatech (NASDAQ:MTEX) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX) in a research note issued to investors on Thursday. The firm set a “buy” rating on the stock.

Mannatech Price Performance

Shares of MTEX stock opened at $8.47 on Thursday. The company has a market cap of $15.97 million, a P/E ratio of -9.52 and a beta of 1.17. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.17 and a quick ratio of 0.62. The stock’s 50-day moving average is $7.54 and its 200 day moving average is $7.61. Mannatech has a 1-year low of $6.75 and a 1-year high of $10.51.

Mannatech (NASDAQ:MTEX) last issued its quarterly earnings data on Tuesday, August 13th. The company reported ($0.33) earnings per share (EPS) for the quarter. The firm had revenue of $27.74 million during the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%.

Insider Activity at Mannatech

In other news, Director Larry A. Jobe sold 16,288 shares of the business’s stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $7.75, for a total transaction of $126,232.00. Following the sale, the director now owns 54,721 shares in the company, valued at approximately $424,087.75. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 41.50% of the stock is currently owned by corporate insiders.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.